Accessibility Menu
 
Onconetix logo

Onconetix

(NASDAQ) BWV

Current PriceN/A
Market CapN/A
Since IPO (2022)-100%
5 YearN/A
1 Year-100%
1 Month-83%

Onconetix Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$735.20K

Net Income (TTM)

$9.70M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

BWV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Onconetix

Industry

Biotechnology

Employees

8

CEO

David Allan White, MBA

Headquarters

Cincinnati, OH 45202, US

BWV Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

-9%

Net Income Margin

-13%

Return on Equity

-1%

Return on Capital

-58%

Return on Assets

-65%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$632.91K

Operating Income

$17.86M

EBITDA

$17.86M

Operating Cash Flow

$9.68M

Capital Expenditure

$0.00

Free Cash Flow

$9.68M

Cash & ST Invst.

$5.22M

Total Debt

$48.77K

Onconetix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$21.46K

-78.9%

Gross Profit

$1.66K

-103.6%

Gross Margin

-7.71%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

12

N/A

Net Income

$4.21M

+50.7%

EBITDA

$10.23M

+18.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$3.43M

+145.9%

Accounts Receivable

$43.73K

+168.4%

Inventory

$137.64K

-11.6%

Long Term Debt

$18.31K

N/A

Short Term Debt

$271.61K

-97.0%

Return on Assets

-65.41%

N/A

Return on Invested Capital

-57.65%

N/A

Free Cash Flow

$2.12M

-6.1%

Operating Cash Flow

$2.12M

-6.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VIVSVivoSim Labs, Inc.
$1.36+1.49%
IDRAIdera Pharmaceuticals, Inc.
$0.42-23.04%
LSTALisata Therapeutics, Inc.
$3.14+0.00%
QTTBQ32 Bio Inc.
$5.80+5.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About BWV

What is the current price of Onconetix?

Onconetix is trading at N/A per share.

What is the 52-week range for Onconetix?

Over the past 52 weeks, Onconetix has traded between N/A and N/A.

How much debt does Onconetix have?

As of the most recent reporting period, Onconetix reported total debt of $289,922.

How much cash does Onconetix have on hand?

Onconetix reported $3.72M in cash and cash equivalents in its most recent financial results.

What is Onconetix’s dividend yield?

Onconetix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.